First Tracks Biotherapeutics Inc

TRAX | NASDAQ

$44.77

-$0.31 (-0.69%)

Nov 2, 2026, 3:17 PM ET · Market open

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q1 2025 Mar 31, 2025
Cash & Equivalents	168.02M	248.47M	238.2M	385.37M
Short-Term Investments	n/a	37.99M	73.44M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	256K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	9.73M	2.95M	4.76M	-385.37M
Total Current Assets	177.75M	289.4M	316.4M	n/a
Property-Plant & Equipment	5.4M	1.17M	13.89M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.39M	1.17M	14.15M	n/a
Total Assets	183.14M	290.58M	330.55M	n/a
Account Payables	2.55M	7.5M	3.11M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	2.44M	n/a	2.08M	n/a
Other Current Liabilities	5.49M	4.86M	n/a	n/a
Total Current Liabilities	12.45M	33.11M	31.02M	n/a
Long-Term Debt	n/a	n/a	12.03M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-391.6M
Total Long-Term Liabilities	1.9M	n/a	12.03M	-391.6M
Total Liabilities	14.34M	33.11M	43.06M	-391.6M
Total Debt	4.33M	n/a	14.11M	n/a
Book Value	168.8M	257.46M	287.49M	n/a
Book Value Per Share	4.77	7.41	8.27	n/a
Common Stock	35K	n/a	n/a	n/a
Retained Earnings	-24.58M	n/a	n/a	n/a
Comprehensive Income	n/a	-146K	-24K	391.6M
Shareholders Equity	168.8M	257.46M	287.49M	391.6M
Total Investments	n/a	37.99M	73.44M	n/a